EMBECTA CORP. Effective Tax Rate
EMBECTA CORP. (EMBC) reported Effective Tax Rate of 23.60% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-07
- EMBECTA CORP. effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was 23.60%, a 36.22% decline year-over-year.
- EMBECTA CORP. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 143.20%, a 316.28% increase year-over-year.
- EMBECTA CORP. effective income tax rate reconciliation, percent for the quarter ending 2025-12-31 was 25.10%, a 74.90% decline year-over-year.
- EMBECTA CORP. effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was 37.00%, a 18.86% decline year-over-year.
- EMBECTA CORP. effective income tax rate reconciliation, percent for fiscal 2025 was 30.00%.
- EMBECTA CORP. effective income tax rate reconciliation, percent for fiscal 2024 was -77.10%, a 330.84% decline from fiscal 2023.
- EMBECTA CORP. effective income tax rate reconciliation, percent for fiscal 2023 was 33.40%, a 158.91% increase from fiscal 2022.
- EMBECTA CORP. effective income tax rate reconciliation, percent for fiscal 2022 was 12.90%, a 20.37% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|
| 2026-06-30 | 23.60% 10-Q · filed 2026-08-07 | 36.40% 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | 143.20% 10-Q · filed 2026-05-05 | 41.50% 10-Q · filed 2026-05-05 | ||
| 2025-12-31 | 25.10% 10-Q · filed 2026-02-05 | |||
| 2025-09-30 | 30.00% 10-K · filed 2025-11-25 | |||
| 2025-06-30 | 37.00% 10-Q · filed 2026-08-07 | 35.70% 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | 34.40% 10-Q · filed 2026-05-05 | 33.00% 10-Q · filed 2026-05-05 | ||
| 2024-12-31 | 100.00% 10-Q · filed 2026-02-05 | |||
| 2024-09-30 | -77.10% 10-K · filed 2025-11-25 | |||
| 2024-06-30 | 45.60% 10-Q · filed 2025-08-08 | -24.40% 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | -191.90% 10-Q · filed 2025-05-09 | -102.50% 10-Q · filed 2025-05-09 | ||
| 2023-12-31 | -40.60% 10-Q · filed 2025-02-06 | |||
| 2023-09-30 | 33.40% 10-K · filed 2025-11-25 | |||
| 2023-06-30 | 24.40% 10-Q · filed 2024-08-09 | 36.00% 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | 42.90% 10-Q · filed 2024-05-09 | 39.00% 10-Q · filed 2024-05-09 | ||
| 2022-12-31 | 37.30% 10-Q · filed 2024-02-09 | |||
| 2022-09-30 | 12.90% 10-K · filed 2024-12-11 | |||
| 2022-06-30 | 15.20% 10-Q · filed 2023-08-08 | 15.20% 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | 15.20% 10-Q · filed 2023-05-12 | 15.20% 10-Q · filed 2023-05-12 | ||
| 2021-12-31 | 15.30% 10-Q · filed 2023-02-14 | |||
| 2021-09-30 | 16.20% 10-K · filed 2023-11-29 | |||
| 2021-06-30 | 16.20% 10-Q · filed 2022-08-15 | 16.00% 10-Q · filed 2022-08-15 | ||
| 2020-09-30 | 12.00% 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |